Shortage outlook · by company · read 11 November 2026
Which drugs does Lannett Company, Inc. have on the FDA shortage list?
Lannett Company, Inc. has 18 presentations of 3 drugs on the FDA shortage list, 2 of them reported unavailable. Each is the company's own report to the FDA, with the date of its last update. A report is the company's statement, not a check of any pharmacy's stock.
Lannett Company, Inc. has 18 presentations of 3 drugs on the FDA shortage list in 11 November 2026.
The company reported 14 available, 2 with limited availability and 2 unavailable.
Drug by drug, as the company reported it
- Methylphenidate (Ritalin and Concerta generics)4 presentations · on the list 3 years and 3 months · last updated 2 November 2026
- Lisdexamfetamine (Vyvanse generics)7 presentations · on the list 3 years and 3 months · last updated 2 November 2026
- Mixed amphetamine salts (Adderall generics)7 presentations · on the list 4 years · last updated 2 November 2026
FDA current shortage listing file, read 11 November 2026. Availability is the company's own statement to the FDA, not a check of any pharmacy's stock.
Where can you go from here?
Look up any medicine to see how long it has been listed and every company that reports it. The FDA explains what a listing means in the FDA's frequently asked questions about drug shortages, and the list itself is the FDA drug shortages database.